Our results demonstrated that the expression of MHC-I molecules is associated with patient prognosis; DDX60 regulates the expression of MHC-I molecules; DDX60 expression is down-regulated in CRC and is a favorable prognostic marker. Here, DDX60 is linked to colorectal carcinoma.